Show simple item record

dc.contributor.authorTUZUN, Yalçın
dc.contributor.authorHAMURYUDAN, Vedat
dc.contributor.authorYAZICI, Hasan
dc.contributor.authorOZYAZGAN, Yılmaz
dc.contributor.authorYURDAKUL, Sebahattin
dc.contributor.authorMoral, Füsun
dc.contributor.authorMAT, C
dc.contributor.authorDireskeneli, Haner
dc.contributor.authorAkoğlu, Tevfik
dc.date.accessioned2021-03-03T20:22:59Z
dc.date.available2021-03-03T20:22:59Z
dc.date.issued1994
dc.identifier.citationHAMURYUDAN V., Moral F., YURDAKUL S., MAT C., TUZUN Y., OZYAZGAN Y., Direskeneli H., Akoğlu T., YAZICI H., "SYSTEMIC INTERFERON-ALPHA-2B TREATMENT IN BEHCETS-SYNDROME", JOURNAL OF RHEUMATOLOGY, cilt.21, sa.6, ss.1098-1100, 1994
dc.identifier.issn0315-162X
dc.identifier.othervv_1032021
dc.identifier.otherav_59a3205a-4fa6-422f-b521-dc50ef00d847
dc.identifier.urihttp://hdl.handle.net/20.500.12627/63055
dc.description.abstractObjective. To test the efficacy of systemic interferon alpha 2b (IFN-alpha 2b) treatment in the mucocutaneous and joint symptoms of Behcet's syndrome.
dc.language.isoeng
dc.subjectİmmünoloji ve Romatoloji
dc.subjectSağlık Bilimleri
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectROMATOLOJİ
dc.titleSYSTEMIC INTERFERON-ALPHA-2B TREATMENT IN BEHCETS-SYNDROME
dc.typeMakale
dc.relation.journalJOURNAL OF RHEUMATOLOGY
dc.contributor.department, ,
dc.identifier.volume21
dc.identifier.issue6
dc.identifier.startpage1098
dc.identifier.endpage1100
dc.contributor.firstauthorID3144


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record